Probucol promotes osteoblasts differentiation and prevents osteoporosis development through reducing oxidative stress
Abstract Probucol (PBC) is a potent cholesterol-lowering drug and has been studied extensively for its powerful antioxidative stress. The purpose of this study is to investigate the role of PBC in ovariectomized rat model and to explore the mechanism of osteogenic differentiation of MC3TE-E1 Cells....
Main Authors: | Zhou-Shan Tao, Tian-Lin Li, Shan Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-06-01
|
Series: | Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s10020-022-00503-7 |
Similar Items
-
The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases
by: Arazu Sharif, et al.
Published: (2024-01-01) -
Successful Treatment of Diffuse Normolipemic Plane Xanthoma with Probucol
by: Fumi Miyagawa, et al.
Published: (2013-05-01) -
Effect of probucol on autophagy and apoptosis in the penile tissue of streptozotocin-induced diabetic rats
by: Ke-Qin Zhang, et al.
Published: (2020-01-01) -
EFFECT OF PROBUCOL ON ATHEROSCLEROSIS IN ApoE-/- MICE AND ITS MECHANISM
by: LI Dong, AN Yi
Published: (2023-08-01) -
The ABCA1 blocking agent probucol decreases capacitation in ejaculated dog spermatozoa
by: Sabine Schäfer-Somi, et al.
Published: (2020-01-01)